Literature DB >> 489028

Segregation and linkage analyses of dopamine-beta-hydroxylase activity.

R C Elston, K K Namboodiri, C G Hames.   

Abstract

Dopamine-beta-hydroxylase (DBH) activity in serum was measured by spectrophotometric methods in 95 persons of a large family (HGAR 2), along with 27 polymorphic markers from blood, urine and saliva. The distribution of DBH activity, after appropriate transformation and age adjustment, showed a significantly better fit to a mixture of two normal distributions than a single normal distribution. Pedigree segregation analyses showed evidence of a possible major gene governing low levels of DBH activity, segregating in this family in a recessive fashion. Linkage analyses between that major locus and the 27 polymorphic markers showed no significant lod scores favoring linkage. The highest lod score obtained was 0.81 with Lp at zero recombination fraction. In addition, published data on DBH activity measured by radiochemical assays on 22 families with 161 members were reanalyzed as a quantitative trait, with appropriate correction for ascertainment bias. The results were similar to that of HGAR 2, corroborating the existence of a major locus for DBH activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 489028     DOI: 10.1159/000153059

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  10 in total

1.  Estimation of segregation and linkage parameters in simulated data. I. Segregation analyses with different ascertainment schemes.

Authors:  P L Kramer; D L Pauls; R A Price; K K Kidd
Journal:  Am J Hum Genet       Date:  1989-07       Impact factor: 11.025

2.  Further evidence for a gene influencing spatial ability.

Authors:  G C Ashton; I B Borecki
Journal:  Behav Genet       Date:  1987-05       Impact factor: 2.805

3.  Human plasma dopamine-beta-hydroxylase: oxygen and thermal stability.

Authors:  J Dunnette; R Weinshilboum
Journal:  Experientia       Date:  1981-02-15

4.  Linkage analysis of plasma dopamine β-hydroxylase activity in families of patients with schizophrenia.

Authors:  Joseph F Cubells; Xiangqing Sun; Wenbiao Li; Robert W Bonsall; John A McGrath; Dimitri Avramopoulos; Virginia K Lasseter; Paula S Wolyniec; Yi-Lang Tang; Kristina Mercer; Ann E Pulver; Robert C Elston
Journal:  Hum Genet       Date:  2011-04-21       Impact factor: 4.132

5.  A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus.

Authors:  C P Zabetian; G M Anderson; S G Buxbaum; R C Elston; H Ichinose; T Nagatsu; K S Kim; C H Kim; R T Malison; J Gelernter; J F Cubells
Journal:  Am J Hum Genet       Date:  2001-01-19       Impact factor: 11.025

Review 6.  Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology.

Authors:  J F Cubells; C P Zabetian
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

7.  Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase (MAO): possible linkage between the ABO locus and a gene controlling DBH activity.

Authors:  L R Goldin; E S Gershon; C R Lake; D L Murphy; M McGinniss; R S Sparkes
Journal:  Am J Hum Genet       Date:  1982-03       Impact factor: 11.025

8.  Family studies of plasma dopamine-beta-hydroxylase thermal stability.

Authors:  J Dunnette; R Weinshilboum
Journal:  Am J Hum Genet       Date:  1982-01       Impact factor: 11.025

9.  Linkage of a gene regulating dopamine-beta-hydroxylase activity and the ABO blood group locus.

Authors:  A F Wilson; R C Elston; R M Siervogel; L D Tran
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

10.  Association of social and cognitive impairment and biomarkers in autism spectrum disorders.

Authors:  Altaf Alabdali; Laila Al-Ayadhi; Afaf El-Ansary
Journal:  J Neuroinflammation       Date:  2014-01-08       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.